Entresto, which costs about $12.50 a day or $4,560 per year, was approved by the U.S. Food and Drug Administration in July. US health insurer, Entresto , and Joe Jimenez , the Swiss drug maker, have agreed on a performance-based price for its new heart drug, Cigna . Payments will be based on the reduction in the proportion of Cigna customers who are admitted to hospital for heart failure. Drugmakers and US managed-care companies have made some performance-based deals to cut unnecessary drug spending after drug prices jumped 17 percent in the US Feb 8 , though few have been made public.
US health insurer, Entresto , and Joe Jimenez , the Swiss drug maker, have agreed on a performance-based price for its new heart drug, Cigna . Payments will be based on the reduction in the proportion of Cigna customers who are admitted to hospital for heart failure. Drugmakers and US managed-care companies have made some performance-based deals to cut unnecessary drug spending after drug prices jumped 17 percent in the US Feb 8 , though few have been made public.